文献速递生殖医学

抗抑郁药使用与辅助生殖技术治疗结局:丹麦全国登记队列研究

Use of antidepressants and assisted reproductive technology treatment outcomes: a Danish nationwide register-based cohort study.
PubMed 文献 · Fertil Steril · 2026-02-25

该研究纳入2006至2019年丹麦44,542名接受ART治疗的女性共123,146个胚胎移植周期,比较当前或近期使用抗抑郁药与未使用者的临床妊娠和活产率。结果显示当前或近期使用抗抑郁药与临床妊娠或活产几率降低无关,提示接受抗抑郁药治疗的女性ART成功率与未使用者相当。

要点

  • 当前使用抗抑郁药者调整后临床妊娠RR 0.96(95%CI 0.87-1.03),活产RR 0.96(95%CI 0.87-1.00)。
  • 近期使用抗抑郁药者调整后临床妊娠RR 0.94(95%CI 0.86-1.01),活产RR 1.04(95%CI 0.90-1.20)。
  • 胚胎移植时当前或近期使用抗抑郁药未显示降低临床妊娠或活产几率。

核心结论

  • 基于十余年全国数据,胚胎移植时当前或近期使用抗抑郁药与临床妊娠或活产几率降低无关。
  • 接受抗抑郁药治疗的女性ART治疗成功率与未使用者相当。

研究设计与样本

  • 基于丹麦全国登记资料的观察性队列研究,纳入2006至2019年所有接受ART治疗的丹麦女性。
  • 共44,542名女性,123,146个胚胎移植周期。
  • 暴露组为胚胎移植时当前使用抗抑郁药者或移植前已停药者(近期使用者),反映轻中度抑郁。
  • 未暴露组为无抗抑郁药使用史的女性。
  • 采用多水平混合效应广义线性模型,考虑多次胚胎移植。

主要发现

  • 当前使用者1,057名女性(中位年龄35岁,IQR 31-39),共2,154个移植周期。
  • 近期使用者1,580名女性,共2,780个移植周期;未使用者42,861名女性,共118,212个移植周期。
  • 当前使用者临床妊娠RR 0.97(95%CI 0.90-1.04),活产RR 0.94(95%CI 0.79-1.11)。
  • 当前使用者调整后临床妊娠RR 0.96(95%CI 0.87-1.03),活产RR 0.96(95%CI 0.87-1.00)。
  • 近期使用者临床妊娠RR 0.94(95%CI 0.87-1.00),活产RR 0.99(95%CI 0.85-1.14);调整后临床妊娠RR 0.94(95%CI 0.86-1.01),活产RR 1.04(95%CI 0.90-1.20)。

临床怎么用

  • 对于轻中度抑郁且接受抗抑郁药治疗的女性,胚胎移植时无需因担心降低成功率而停用抗抑郁药。
  • 临床咨询可告知此类女性ART治疗成功率与未使用抗抑郁药者相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the association between antidepressants and clinical pregnancy and live birth after embryo transfer in women with mild to moderate depression. DESIGN: This register-based observational study comprised all Danish women undergoing assisted reproductive technology (ART) treatment from 2006 to 2019. SUBJECTS: A nationwide cohort of 44,542 women with 123,146 embryo transfers. EXPOSURE: The exposed cohorts were either women exposed to antidepressants at the time of embryo transfer (current users) or women who discontinued treatment before embryo transfer (recent users), reflecting mild to moderate depression. Women without a history of antidepressant use constituted the unexposed cohort. MAIN OUTCOME MEASURES: We used a multilevel mixed-effects generalized linear model, accounting for multiple embryo transfers, to examine the chance of clinical pregnancy and live birth after ART treatment in women currently or recently treated with antidepressants, compared with women without antidepressants. RESULTS: A total of 1,057 women (median age 35 [interquartile range: 31-39]) were current users and had 2,154 embryo transfers, 1,580 women were recent users and had 2,780 transfers, and 42,861 women without use of antidepressants had 118,212 transfers. The relative risk (RR) of clinical pregnancy in women with current use was 0.97 (95% confidence interval [CI]: 0.90-1.04), and 0.94 (95% CI: 0.79-1.11) for live birth. The confounder-adjusted RR was 0.96 (95% CI: 0.87-1.03) for clinical pregnancy, and 0.96 (95% CI: 0.87-1.00) for live birth among current users. For recent users, the RRs of clinical pregnancy, and live birth were 0.94 (95% CI: 0.87-1.00), and 0.99 (95% CI: 0.85-1.14), respectively, and the adjusted RRs 0.94 (95% CI: 0.86-1.01) for clinical pregnancy and 1.04 (95% CI: 0.90-1.20) for live birth. CONCLUSION: Based on nationwide data from more than a decade, we found that current or recent use of antidepressants at the time of embryo transfer was not associated with a decreased chance of clinical pregnancy or live birth. The findings suggest that for women treated with antidepressants, ART treatment is as successful as for women without.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Jølving LR, Munk-Olsen T, Torseth O, et al. Use of antidepressants and assisted reproductive technology treatment outcomes: a Danish nationwide register-based cohort study. Fertil Steril. 2026. PMID: 41759609. doi:10.1016/j.fertnstert.2026.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。